GSA Capital Partners’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $600K | Buy |
|
|||||
|
2025
Q1 | $548K | Sell |
|
|||||
|
2024
Q4 | $1.31M | Buy |
|
|||||
|
2024
Q3 | $625K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $954K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $744K | Buy |
|
|||||
|
2022
Q1 | $300K | Buy |
|
|||||
|
2021
Q4 | $162K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $137K | Sell |
|
|||||
|
2021
Q1 | $419K | Sell |
|
|||||
|
2020
Q4 | $336K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $330K | Sell |
|
|||||
|
2019
Q4 | $703K | Buy |
|
|||||
|
2019
Q3 | $184K | Buy |
|
|||||
|
2019
Q2 | $101K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $767K | Sell |
|
|||||
|
2018
Q2 | $1.19M | Buy |
|
|||||
|
2018
Q1 | $230K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $1.21M | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $812K | Buy |
|
|||||
|
2016
Q2 | $440K | Buy |
|